Although it is well-known that BRCA1/2-positive women report on average, higher levels of anxiety and depression than the general population, these increases have not been directly connected to the COVID-19 pandemic, but within past literature have focused on the stress of ongoing surveillance and prophylactic risk-reducing surgeries18,42,43 and cancer patients generally44. The gene discussed is BRCA1; the disease is depressive symptom measurement.